Similar articles

• [Treatment of angina pectoris with perhexiline maleate. Clinical evaluation in controlled double-blind study with placebo and prenylamine].

  Dalla Volta S, Episcopo U, Gemelli A, Permutti B. Dalla Volta S, et al. Minerva Cardioangiol. 1976 Feb;24(2):137-47. Minerva Cardioangiol. 1976. PMID: 768808 Clinical Trial. Italian. No abstract available.
• [Effects of perhexiline maleate in angina pectoris: preliminary clinical and experimental results of a comparative study].

  Caponnetto S, Iannetti M, Pastorini C, Masperone MA, Perugini P. Caponnetto S, et al. Boll Soc Ital Cardiol. 1975;20(11):1433-7. Boll Soc Ital Cardiol. 1975. PMID: 791305 Clinical Trial. Italian. No abstract available.
• [Perhexiline maleate in the treatment of angina pectoris - double blind study].

  Cunha GP, Lopes M, Maranhão MF, Oliveira PF, Rojas RI. Cunha GP, et al. Arq Bras Cardiol. 1975 Jun;28(3):379-37. Arq Bras Cardiol. 1975. PMID: 1101858 Clinical Trial. Portuguese. No abstract available.
• [Cirrhogenic hepatitis due to perhexiline maleate: general review based upon one new case with ultrastructural study (author's transl)].

  Bertrand L, Baldet P, Blanc F, Puyeo J. Bertrand L, et al. Ann Med Interne (Paris). 1978 Oct;129(10):565-74. Ann Med Interne (Paris). 1978. PMID: 369426 Review. French.
• Is perhexiline essential for the optimal management of angina pectoris?

  Horowitz JD, Button IK, Wing L. Horowitz JD, et al. Aust N Z J Med. 1995 Apr;25(2):111-3. doi: 10.1111/j.1445-5994.1995.tb02820.x. Aust N Z J Med. 1995. PMID: 7605290 Review. No abstract available.